Chargement en cours...
BRAF(V600) mutant non-small-cell lung cancer resistant to Vemurafenib
Vemurafenib has shown significant activity in V600 mutant melanoma; however the role of this agent in Lung adenocarcinoma with an activating BRAF mutation is still evolving. One of our patients had a rare activating BRAF mutation detected through tumor exome sequencing, which led to a switch from he...
Enregistré dans:
| Publié dans: | Int J Clin Exp Pathol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4440164/ https://ncbi.nlm.nih.gov/pubmed/26045855 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|